Organogenesis Holdings Inc. (ORGO) Stock Overview
Explore Organogenesis Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.
Organogenesis Holdings Inc. (ORGO)
Key Financials
Key Financials
Market Cap
232.9M
P/E Ratio
-2.18
EPS (TTM)
$0.03
ROE
-0.24%
ORGO Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Organogenesis Holdings Inc. (NASDAQ: ORGO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Organogenesis Holdings Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ORGO on the NASDAQ shows an RSI of 32.41, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.73 for the NASDAQ listing.
Key metrics behind Organogenesis Holdings Inc.'s NASDAQ-traded stock include a P/E ratio of -2.18 and a market capitalization of 232.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ORGO on the NASDAQ.